ABBOTT LABORATORIES — Director's Dealing 2019

May 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-05-23

Reporting Person: Blaser Brian J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-23	Common shares without par value	M	165000	$34.94	Acquired	295745	Direct
2019-05-23	Common shares without par value	M	175164	$39.12	Acquired	470909	Direct
2019-05-23	Common shares without par value	M	53163	$47.00	Acquired	524072	Direct
2019-05-23	Common shares without par value	M	56735	$38.40	Acquired	580807	Direct
2019-05-23	Common shares without par value	S	450062	$75.5201	Disposed	130745	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-23	Option (right to buy)	$34.94	M	165000	Disposed	2023-02-14	Common shares (165000)	Direct
2019-05-23	Option (right to buy)	$39.12	M	175164	Disposed	2024-02-20	Common shares (175164)	Direct
2019-05-23	Option (right to buy)	$47.00	M	53163	Disposed	2025-02-19	Common shares (53163)	Direct
2019-05-23	Option (right to buy)	$38.40	M	56735	Disposed	2026-02-18	Common shares (56735)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.70, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.